VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,395 | -10.5% | 7,744 | +0.2% | 0.02% | -23.3% |
| Q2 2023 | $232,720 | -36.9% | 7,729 | -32.2% | 0.03% | -48.3% |
| Q1 2023 | $368,758 | +16.7% | 11,399 | +3.4% | 0.06% | +5.5% |
| Q4 2022 | $315,919 | +13.6% | 11,023 | -4.6% | 0.06% | +10.0% |
| Q3 2022 | $278,000 | -7.9% | 11,560 | +4.7% | 0.05% | -7.4% |
| Q2 2022 | $302,000 | -30.1% | 11,044 | -2.7% | 0.05% | -59.4% |
| Q1 2022 | $432,000 | -37.6% | 11,346 | -47.5% | 0.13% | +5.6% |
| Q4 2021 | $692,000 | -18.2% | 21,625 | -24.7% | 0.13% | -38.2% |
| Q3 2021 | $846,000 | +22.4% | 28,714 | +32.5% | 0.20% | -41.9% |
| Q2 2021 | $691,000 | +20.4% | 21,677 | +21.6% | 0.35% | -1.1% |
| Q1 2021 | $574,000 | +60.8% | 17,821 | +79.4% | 0.36% | +29.6% |
| Q4 2020 | $357,000 | +15.2% | 9,932 | +25.4% | 0.27% | -2.8% |
| Q3 2020 | $310,000 | – | 7,921 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |